BG107679A - Натриеви соли на 5-[4-[2-(n-метил-n-(2-пиридил)амино)етокси]бензил]тиазолидин-2,4-дион - Google Patents

Натриеви соли на 5-[4-[2-(n-метил-n-(2-пиридил)амино)етокси]бензил]тиазолидин-2,4-дион Download PDF

Info

Publication number
BG107679A
BG107679A BG107679A BG10767903A BG107679A BG 107679 A BG107679 A BG 107679A BG 107679 A BG107679 A BG 107679A BG 10767903 A BG10767903 A BG 10767903A BG 107679 A BG107679 A BG 107679A
Authority
BG
Bulgaria
Prior art keywords
sodium salt
thiazolidine
pyridyl
benzyl
ethoxy
Prior art date
Application number
BG107679A
Other languages
Bulgarian (bg)
English (en)
Inventor
Andrew Craig
Michael Millan
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of BG107679A publication Critical patent/BG107679A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG107679A 2000-09-29 2003-03-26 Натриеви соли на 5-[4-[2-(n-метил-n-(2-пиридил)амино)етокси]бензил]тиазолидин-2,4-дион BG107679A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0023971.5A GB0023971D0 (en) 2000-09-29 2000-09-29 Novel pharmaceutical
PCT/GB2001/004334 WO2002026735A1 (en) 2000-09-29 2001-09-28 Sodium salts of 5-'4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione

Publications (1)

Publication Number Publication Date
BG107679A true BG107679A (bg) 2003-12-31

Family

ID=9900428

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107679A BG107679A (bg) 2000-09-29 2003-03-26 Натриеви соли на 5-[4-[2-(n-метил-n-(2-пиридил)амино)етокси]бензил]тиазолидин-2,4-дион

Country Status (27)

Country Link
US (4) US20040014752A1 (ko)
EP (2) EP1813612A1 (ko)
JP (1) JP2004509959A (ko)
KR (1) KR100917953B1 (ko)
CN (4) CN101125853A (ko)
AP (1) AP1738A (ko)
AU (2) AU9202801A (ko)
BG (1) BG107679A (ko)
BR (1) BR0114308A (ko)
CA (1) CA2423975A1 (ko)
CZ (1) CZ302181B6 (ko)
DZ (1) DZ3480A1 (ko)
EA (1) EA005109B1 (ko)
EC (1) ECSP034528A (ko)
GB (1) GB0023971D0 (ko)
HU (1) HUP0301188A3 (ko)
IL (2) IL155051A0 (ko)
MA (1) MA25912A1 (ko)
MX (1) MXPA03002868A (ko)
NO (2) NO20031435L (ko)
NZ (1) NZ524933A (ko)
OA (1) OA12399A (ko)
PL (1) PL363701A1 (ko)
SK (1) SK3782003A3 (ko)
UA (1) UA74842C2 (ko)
WO (1) WO2002026735A1 (ko)
ZA (1) ZA200302439B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8133637B2 (en) * 2005-10-06 2012-03-13 Headwaters Technology Innovation, Llc Fuel cells and fuel cell catalysts incorporating a nanoring support
US7435741B2 (en) 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
PL2512470T3 (pl) * 2009-12-15 2017-06-30 Octeta Therapeutics, Llc Oszczędzające ppar tiazolidynodiony i połączenia do leczenia chorób neurodegeneracyjnych

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856378T2 (de) * 1987-09-04 2000-05-11 Beecham Group Plc Substituierte Thiazolidindionderivate
GB9124513D0 (en) * 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9308487D0 (en) * 1993-04-23 1993-06-09 Smithkline Beecham Plc Novel compounds
GB9723295D0 (en) * 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
CN1253236A (zh) * 1998-11-11 2000-05-17 李扬远 一种以重力差释放引力能的方法
CN1183130C (zh) * 1999-09-24 2005-01-05 中国人民解放军军事医学科学院毒物药物研究所 噻唑烷类衍生物及其医药用途
HU225919B1 (en) * 1999-12-18 2007-12-28 Richter Gedeon Nyrt Thiazolidine-derivatives, process for their preparation pharmaceutical and intermediates
GB0006133D0 (en) * 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
OA12399A (en) 2004-09-06
MXPA03002868A (es) 2004-12-06
NO20031435L (no) 2003-05-27
CN101125853A (zh) 2008-02-20
GB0023971D0 (en) 2000-11-15
MA25912A1 (fr) 2003-10-01
EA200300422A1 (ru) 2003-08-28
CZ302181B6 (cs) 2010-12-01
CN100345846C (zh) 2007-10-31
HUP0301188A2 (hu) 2003-11-28
UA74842C2 (en) 2006-02-15
JP2004509959A (ja) 2004-04-02
CN101125852A (zh) 2008-02-20
IL155051A0 (en) 2003-10-31
US20040014752A1 (en) 2004-01-22
US20060004058A1 (en) 2006-01-05
ZA200302439B (en) 2004-04-28
AU9202801A (en) 2002-04-08
HUP0301188A3 (en) 2005-04-28
PL363701A1 (en) 2004-11-29
EA005109B1 (ru) 2004-10-28
CN1915992B (zh) 2010-05-12
AP2003002767A0 (en) 2003-03-31
AU2001292028B2 (en) 2005-04-21
US20040214866A1 (en) 2004-10-28
ECSP034528A (es) 2003-05-26
CN1915992A (zh) 2007-02-21
BR0114308A (pt) 2003-10-14
CN1466585A (zh) 2004-01-07
DZ3480A1 (fr) 2002-04-04
KR100917953B1 (ko) 2009-09-21
SK3782003A3 (en) 2004-06-08
IL188116A0 (en) 2008-03-20
NO20076517L (no) 2003-04-29
US20070185167A1 (en) 2007-08-09
WO2002026735A1 (en) 2002-04-04
US20050277679A9 (en) 2005-12-15
EP1813612A1 (en) 2007-08-01
CA2423975A1 (en) 2002-04-04
NZ524933A (en) 2004-12-24
EP1332142A1 (en) 2003-08-06
CZ2003850A3 (cs) 2004-03-17
AP1738A (en) 2007-05-07
KR20030039377A (ko) 2003-05-17
NO20031435D0 (no) 2003-03-28

Similar Documents

Publication Publication Date Title
SK286399B6 (sk) V podstate nehydratovaná a nehygroskopická alebo iba mierne hygroskopická hydrochloridová soľ 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu, spôsob jej prípravy, farmaceutický prostriedok s jej obsahom a jej použitie
KR20020028873A (ko) 티아졸리딘디온 유도체 및 항당뇨병제로서 그의 용도
US20070185167A1 (en) Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
SK1442003A3 (en) Tartrate salts of thiazolidinedione derivative
EP1305311B1 (en) Tartrate salt of thiazolidinedione derivative
WO2003050113A1 (en) Hydrogensulfate salt of 5-'4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy!benzyl!thia zolidine-2,4-dione
BG107605A (bg) Тартаратни соли на тиазолидиндионово производно
AU2001292028A1 (en) Sodium salts of 5-'4-'2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2,4-dione
BG107678A (bg) Тиазолидиндионово производно и използването му като антидиабетично средство
SK17152002A3 (sk) Hydrojodid 5-[4-[2-(N-metyl-N-(2-pyridyl)amíno)etoxy]- benzyl]tiazolidín-2,4-diónu ako liečivo
US20040102485A1 (en) Tartrate salt of thiazolidinedione derivative
SK1432003A3 (en) Tartrate salts of thiazolidinedione derivative
WO2003050114A1 (en) Sulfate salt of a thiazolidinedione derivative